SPX4,274.04-31.16 -0.72%
DIA340.20-1.54 -0.45%
IXIC12,938.12-164.43 -1.25%

BRIEF-Pfizer Planning To Deliver Both Ba.1 And Ba.4/5 Targeted Covid-19 Vaccines In The Fall

BRIEF-Pfizer Planning To Deliver Both Ba.1 And Ba.4/5 Targeted Covid-19 Vaccines In The Fall

Reuters · 07/28/2022 07:48
BRIEF-Pfizer Planning To Deliver Both Ba.1 And Ba.4/5 Targeted Covid-19 Vaccines In The Fall

- Pfizer Inc PFE:

  • PFIZER SAYS TO DATE, WE HAVE SHIPPED MORE THAN 3.6 BILLION DOSES OF OUR VACCINE TO 180 COUNTRIES AND TERRITORIES AROUND THE WORLD - PREPARED REMARKS

  • PFIZER SAYS PLANNING TO DELIVER BOTH BA.1 AND BA.4/5 TARGETED COVID-19 VACCINES IN THE FALL, PENDING REGULATORY APPROVALS

  • PFIZER SAYS WELL POSITIONED TO SATISFY CURRENT CONTRACTUAL OBLIGATIONS TO THE U.S. FOR COVID-19 BA.4/BA.5 BOOSTER VACCINE THROUGH THE END OF THE YEAR

  • PFIZER INC SAYS WORKING WITH THE FDA TO FINALIZE A PROTOCOL TO STUDY PAXLOVID USE IN PATIENTS WHO MAY BE IN NEED OF RETREATMENT

  • PFIZER SAYS INTERNAL ESTIMATES SHOWED 116% INCREASE OF PAXLOVID USAGE IN INTERNATIONAL DEVELOPED MARKETS BETWEEN JUNE 24 AND JULY 15

  • PFIZER INC SAYS BELIEVES THE OCCURRENCE OF COVID-19 REBOUND AFTER PAXLOVID IS UNCOMMON AND NOT UNIQUELY ASSOCIATED WITH ANY SPECIFIC TREATMENT

  • PFIZER SAYS BASED ON CURRENT FY GUIDANCE FOR PAXLOVID, WE EXPECT APPROXIMATELY 60% OF SALES IN Q3 AND 40% IN Q4

  • PFIZER SAYS BASED ON CURRENT FY GUIDANCE FOR COMIRNATY, EXPECT APPROXIMATELY 25% OF SECOND HALF SALES IN Q3 AND 75% OF SALES IN Q4

  • PFIZER - CUMULATIVE SHARE OF COMIRNATY DOSES ADMINISTERED IN MARKETS IN WHICH CO OPERATES INCREASED FROM 52% ON JAN 1, 2022, TO 63% ON JULY 20, 2022

  • PFIZER SAYS IN DEVELOPED MARKETS, SHARE OF COMIRNATY DOSES ADMINISTERED HAS INCREASED FROM 59% TO 68% OVER JAN 1 TO JULY 20, 2022


Further company coverage: PFE


((Reuters.Briefs@thomsonreuters.com;))